July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Complement factor H (CFH) loss leads to a local complement system activation and impaired cell balance in the RPE cells
Author Affiliations & Notes
  • Angela Armento
    Department for Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany
  • Sabina Honisch
    Department for Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany
  • Anke Jacob
    Department for Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany
  • Dragana Trifunovic
    Department for Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany
  • Marius Ueffing
    Department for Ophthalmology, Institute for Ophthalmic Research, Tübingen, Germany
  • Footnotes
    Commercial Relationships   Angela Armento, None; Sabina Honisch, None; Anke Jacob, None; Dragana Trifunovic, None; Marius Ueffing, None
  • Footnotes
    Support  H2020 project EYE-RISK, GA no 634479
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1242. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Angela Armento, Sabina Honisch, Anke Jacob, Dragana Trifunovic, Marius Ueffing; Complement factor H (CFH) loss leads to a local complement system activation and impaired cell balance in the RPE cells. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1242. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Age related macular degeneration (AMD) is the leading cause of blindness in the elderly population. Although the etiology of AMD is still not fully elucidated, complement system (CS) dysregulation is involved and genetic variants of complement genes, like CFH, are major drivers of AMD. The contribution of CFH, the key regulator of the CS, to local complement activation in the retina and its influence on RPE cells homeostasis still remain vague. We hypothesized that CFH plays a protective role in the RPE and its absence contributes to AMD pathology.

Methods : To investigate the role of CFH, we used shRNA to silence CFH in hTERT-RPE-1 cells and evaluated by RT-qPCR (n=3, FC ± SEM) whether CFH reduction has an impact on the expression of other complement factors and inflammatory cytokines. We also used ELISA, to establish if CFH reduction influences CS activation. The effects of CFH depletion on RPE cells were assessed, under normal condition and under H2O2 -induced oxidative stress, via cell viability, cell density, cytotoxicity and caspase activity assays.

Results : CFH depletion led to a significant upregulation of several genes involved in the activation of the CS including complement component 3 (C3; 6.3 ± 0.9, p=0.005) and complement factor B (CFB; 12.9 ± 4.2, p=0.05). At the same time, the expression of pro-inflammatory cytokines like C-C Motif Chemokine Ligand 2 (CCL2) was increased as well as the pro-angiogenic vascular endothelial growth factor (VEGF). Reduced level of CFH translated in a significant increase in C3b concentration (13.6 ± 2.2 ng/ml, p=0.04) compared to controls (7.2 ± 0.8 ng/ml), indicating a local complement activation mediated solely by RPE cells. Moreover, CFH downregulation severely affected RPE cells homeostasis, leading to increased cytotoxicity in both, normal and H2O2- stressed RPE cells. These effects were accompanied by a higher caspase 3/7 activity (2.9 ± 0.1, p=0.001). Interestingly, cell viability was affected only after H2O2 treatment in absence of CFH.

Conclusions : Our data support the hypothesis that CFH is protective in RPE cells. As a result of CFH depletion, RPE cell balance is strongly impaired due to the local activation of the complement system and a pro-inflammatory environment. These findings may help elucidating the function of CFH in the retina and the role of complement in the pathogenesis of AMD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×